LHC Group, Inc. (NASDAQ: LHCG) Stock Competitors & Peer Comparison
See LHCG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for LHCG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LHCG | $169.81 | +0.00% | 5.3B | 82.83 | $2.05 | N/A |
| HCA | $420.26 | +4.54% | 91.3B | 14.57 | $28.96 | +0.71% |
| THC | $268.45 | +3.62% | 21.7B | 15.61 | $17.24 | N/A |
| EHC | $123.59 | +2.59% | 12.1B | 20.82 | $5.84 | +0.63% |
| FMS | $22.40 | -0.22% | 12B | 8.39 | $2.66 | +3.87% |
| DVA | $183.24 | +1.77% | 11.7B | 14.30 | $12.80 | N/A |
| UHS | $176.19 | +2.50% | 10.6B | 7.80 | $22.54 | +0.45% |
| ENSG | $174.46 | +2.30% | 10B | 24.89 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $45.17 | +3.43% | 7.1B | 23.59 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
LHCG vs HCA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, HCA has a market cap of 91.3B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while HCA trades at $420.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas HCA's P/E ratio is 14.57. In terms of profitability, LHCG's ROE is +0.04%, compared to HCA's ROE of -1.13%. Regarding short-term risk, LHCG is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
LHCG vs THC Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, THC has a market cap of 21.7B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while THC trades at $268.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas THC's P/E ratio is 15.61. In terms of profitability, LHCG's ROE is +0.04%, compared to THC's ROE of +0.51%. Regarding short-term risk, LHCG is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
LHCG vs EHC Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while EHC trades at $123.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas EHC's P/E ratio is 20.82. In terms of profitability, LHCG's ROE is +0.04%, compared to EHC's ROE of +0.25%. Regarding short-term risk, LHCG is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
LHCG vs FMS Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, FMS has a market cap of 12B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while FMS trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas FMS's P/E ratio is 8.39. In terms of profitability, LHCG's ROE is +0.04%, compared to FMS's ROE of +0.07%. Regarding short-term risk, LHCG is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
LHCG vs DVA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, DVA has a market cap of 11.7B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while DVA trades at $183.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas DVA's P/E ratio is 14.30. In terms of profitability, LHCG's ROE is +0.04%, compared to DVA's ROE of -1.24%. Regarding short-term risk, LHCG is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
LHCG vs UHS Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, UHS has a market cap of 10.6B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while UHS trades at $176.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas UHS's P/E ratio is 7.80. In terms of profitability, LHCG's ROE is +0.04%, compared to UHS's ROE of +0.21%. Regarding short-term risk, LHCG is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
LHCG vs ENSG Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while ENSG trades at $174.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas ENSG's P/E ratio is 24.89. In terms of profitability, LHCG's ROE is +0.04%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, LHCG is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
LHCG vs OSH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas OSH's P/E ratio is -17.65. In terms of profitability, LHCG's ROE is +0.04%, compared to OSH's ROE of +4.64%. Regarding short-term risk, LHCG is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
LHCG vs PACS Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, PACS has a market cap of 7.1B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while PACS trades at $45.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas PACS's P/E ratio is 23.59. In terms of profitability, LHCG's ROE is +0.04%, compared to PACS's ROE of +0.27%. Regarding short-term risk, LHCG is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
LHCG vs CHE Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while CHE trades at $519.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas CHE's P/E ratio is 24.00. In terms of profitability, LHCG's ROE is +0.04%, compared to CHE's ROE of +0.29%. Regarding short-term risk, LHCG is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
LHCG vs HIMS Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while HIMS trades at $27.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas HIMS's P/E ratio is -43.62. In terms of profitability, LHCG's ROE is +0.04%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, LHCG is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check HIMS's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
LHCG vs LFST Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while LFST trades at $13.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas LFST's P/E ratio is 95.05. In terms of profitability, LHCG's ROE is +0.04%, compared to LFST's ROE of +0.03%. Regarding short-term risk, LHCG is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
LHCG vs CON Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while CON trades at $34.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas CON's P/E ratio is 21.50. In terms of profitability, LHCG's ROE is +0.04%, compared to CON's ROE of +0.47%. Regarding short-term risk, LHCG is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check CON's competition here
National HealthCare Corporation (AMEX: NHC)
LHCG vs NHC Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while NHC trades at $229.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas NHC's P/E ratio is 29.09. In terms of profitability, LHCG's ROE is +0.04%, compared to NHC's ROE of +0.13%. Regarding short-term risk, LHCG is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
LHCG vs OPCH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, OPCH has a market cap of 3.5B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while OPCH trades at $23.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas OPCH's P/E ratio is 13.74. In terms of profitability, LHCG's ROE is +0.04%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, LHCG is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
LHCG vs AMED Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AMED's P/E ratio is 39.30. In terms of profitability, LHCG's ROE is +0.04%, compared to AMED's ROE of +0.11%. Regarding short-term risk, LHCG is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
LHCG vs AVAH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AVAH has a market cap of 3.1B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AVAH trades at $14.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AVAH's P/E ratio is 20.62. In terms of profitability, LHCG's ROE is +0.04%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, LHCG is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
LHCG vs BKD Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, BKD has a market cap of 2.9B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while BKD trades at $12.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas BKD's P/E ratio is -20.94. In terms of profitability, LHCG's ROE is +0.04%, compared to BKD's ROE of +4.06%. Regarding short-term risk, LHCG is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check BKD's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
LHCG vs GRDN Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while GRDN trades at $44.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas GRDN's P/E ratio is 38.03. In terms of profitability, LHCG's ROE is +0.04%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, LHCG is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check GRDN's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
LHCG vs ACHC Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while ACHC trades at $29.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas ACHC's P/E ratio is 14.17. In terms of profitability, LHCG's ROE is +0.04%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, LHCG is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check ACHC's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
LHCG vs ADUS Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while ADUS trades at $120.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas ADUS's P/E ratio is 17.85. In terms of profitability, LHCG's ROE is +0.04%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, LHCG is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
LHCG vs MD Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while MD trades at $27.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas MD's P/E ratio is 12.09. In terms of profitability, LHCG's ROE is +0.04%, compared to MD's ROE of +0.20%. Regarding short-term risk, LHCG is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check MD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
LHCG vs SEM Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas SEM's P/E ratio is 15.43. In terms of profitability, LHCG's ROE is +0.04%, compared to SEM's ROE of +0.08%. Regarding short-term risk, LHCG is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
LHCG vs ASTH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while ASTH trades at $39.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas ASTH's P/E ratio is 45.86. In terms of profitability, LHCG's ROE is +0.04%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, LHCG is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
LHCG vs SNDA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while SNDA trades at $40.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas SNDA's P/E ratio is -6.39. In terms of profitability, LHCG's ROE is +0.04%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, LHCG is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check SNDA's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
LHCG vs SGRY Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while SGRY trades at $14.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas SGRY's P/E ratio is 36.21. In terms of profitability, LHCG's ROE is +0.04%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, LHCG is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
LHCG vs AMEH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AMEH's P/E ratio is 39.25. In terms of profitability, LHCG's ROE is +0.04%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, LHCG is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AMEH's competition here
Ardent Health Inc. (NYSE: ARDT)
LHCG vs ARDT Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while ARDT trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas ARDT's P/E ratio is 8.98. In terms of profitability, LHCG's ROE is +0.04%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, LHCG is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check ARDT's competition here
Agilon Health, Inc. (NYSE: AGL)
LHCG vs AGL Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AGL trades at $96.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AGL's P/E ratio is -6.09. In terms of profitability, LHCG's ROE is +0.04%, compared to AGL's ROE of -1.19%. Regarding short-term risk, LHCG is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
LHCG vs HCSG Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while HCSG trades at $22.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas HCSG's P/E ratio is 17.62. In terms of profitability, LHCG's ROE is +0.04%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, LHCG is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
LHCG vs INNV Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while INNV trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas INNV's P/E ratio is -122.56. In terms of profitability, LHCG's ROE is +0.04%, compared to INNV's ROE of -0.01%. Regarding short-term risk, LHCG is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
LHCG vs PNTG Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while PNTG trades at $40.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas PNTG's P/E ratio is 30.00. In terms of profitability, LHCG's ROE is +0.04%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, LHCG is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
LHCG vs NUTX Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, NUTX has a market cap of 1.4B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while NUTX trades at $197.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas NUTX's P/E ratio is 7.82. In terms of profitability, LHCG's ROE is +0.04%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, LHCG is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check NUTX's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
LHCG vs AMN Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AMN trades at $34.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AMN's P/E ratio is 11.41. In terms of profitability, LHCG's ROE is +0.04%, compared to AMN's ROE of +0.15%. Regarding short-term risk, LHCG is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
LHCG vs BKDT Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas BKDT's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, LHCG is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
LHCG vs USPH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while USPH trades at $78.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas USPH's P/E ratio is 30.60. In terms of profitability, LHCG's ROE is +0.04%, compared to USPH's ROE of -0.01%. Regarding short-term risk, LHCG is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
LHCG vs TALK Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas TALK's P/E ratio is 774.34. In terms of profitability, LHCG's ROE is +0.04%, compared to TALK's ROE of +0.00%. Regarding short-term risk, LHCG is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
LHCG vs GMRS Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, GMRS has a market cap of 707.8M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while GMRS trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas GMRS's P/E ratio is 5.82. In terms of profitability, LHCG's ROE is +0.04%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, LHCG is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
LHCG vs EHAB Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas EHAB's P/E ratio is -197.14. In terms of profitability, LHCG's ROE is +0.04%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, LHCG is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
LHCG vs STLN Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, STLN has a market cap of 628.9M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while STLN trades at $6.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas STLN's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to STLN's ROE of +2.10%. Regarding short-term risk, LHCG is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
LHCG vs TOI Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas TOI's P/E ratio is -14.25. In terms of profitability, LHCG's ROE is +0.04%, compared to TOI's ROE of +2.10%. Regarding short-term risk, LHCG is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
LHCG vs SRTA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, SRTA has a market cap of 451.7M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while SRTA trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas SRTA's P/E ratio is -24.61. In terms of profitability, LHCG's ROE is +0.04%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, LHCG is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
LHCG vs MCTA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas MCTA's P/E ratio is 419.36. In terms of profitability, LHCG's ROE is +0.04%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, LHCG is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
LHCG vs CYH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, CYH has a market cap of 414.6M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while CYH trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas CYH's P/E ratio is 4.03. In terms of profitability, LHCG's ROE is +0.04%, compared to CYH's ROE of +0.21%. Regarding short-term risk, LHCG is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
LHCG vs AUNA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AUNA has a market cap of 384.2M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AUNA trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AUNA's P/E ratio is 4.68. In terms of profitability, LHCG's ROE is +0.04%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, LHCG is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
LHCG vs VMD Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, VMD has a market cap of 333.7M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while VMD trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas VMD's P/E ratio is 24.33. In terms of profitability, LHCG's ROE is +0.04%, compared to VMD's ROE of +0.10%. Regarding short-term risk, LHCG is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
LHCG vs CSU Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas CSU's P/E ratio is 0.67. In terms of profitability, LHCG's ROE is +0.04%, compared to CSU's ROE of -0.33%. Regarding short-term risk, LHCG is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
LHCG vs AIRS Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AIRS has a market cap of 184.1M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AIRS trades at $2.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AIRS's P/E ratio is -87.00. In terms of profitability, LHCG's ROE is +0.04%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, LHCG is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
LHCG vs JYNT Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, JYNT has a market cap of 115.3M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while JYNT trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas JYNT's P/E ratio is 80.90. In terms of profitability, LHCG's ROE is +0.04%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, LHCG is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
LHCG vs FVE Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas FVE's P/E ratio is -5.64. In terms of profitability, LHCG's ROE is +0.04%, compared to FVE's ROE of -0.15%. Regarding short-term risk, LHCG is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
LHCG vs KDLYW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas KDLYW's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, LHCG is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
LHCG vs PARK Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, PARK has a market cap of 94.7M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while PARK trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas PARK's P/E ratio is 28.35. In terms of profitability, LHCG's ROE is +0.04%, compared to PARK's ROE of -0.18%. Regarding short-term risk, LHCG is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
LHCG vs BTMD Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, BTMD has a market cap of 64M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while BTMD trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas BTMD's P/E ratio is 13.18. In terms of profitability, LHCG's ROE is +0.04%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, LHCG is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
LHCG vs ALR Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas ALR's P/E ratio is -1.11. In terms of profitability, LHCG's ROE is +0.04%, compared to ALR's ROE of -0.15%. Regarding short-term risk, LHCG is less volatile compared to ALR. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
LHCG vs DCGO Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, DCGO has a market cap of 36.5M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while DCGO trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas DCGO's P/E ratio is -0.20. In terms of profitability, LHCG's ROE is +0.04%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, LHCG is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
LHCG vs CCEL Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, CCEL has a market cap of 33.1M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while CCEL trades at $4.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas CCEL's P/E ratio is -13.70. In terms of profitability, LHCG's ROE is +0.04%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, LHCG is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
LHCG vs IMAC Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas IMAC's P/E ratio is -2.27. In terms of profitability, LHCG's ROE is +0.04%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, LHCG is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
LHCG vs PIII Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, PIII has a market cap of 28.2M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while PIII trades at $8.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas PIII's P/E ratio is -0.26. In terms of profitability, LHCG's ROE is +0.04%, compared to PIII's ROE of +1.61%. Regarding short-term risk, LHCG is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
LHCG vs EUDA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, EUDA has a market cap of 24.5M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while EUDA trades at $13.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas EUDA's P/E ratio is -24.74. In terms of profitability, LHCG's ROE is +0.04%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, LHCG is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
LHCG vs CANO-WT Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, LHCG is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
LHCG vs AIH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AIH's P/E ratio is -2.78. In terms of profitability, LHCG's ROE is +0.04%, compared to AIH's ROE of +1.16%. Regarding short-term risk, LHCG is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
LHCG vs PIIIW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, PIIIW has a market cap of 14.9M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas PIIIW's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, LHCG is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO)
LHCG vs CANO Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas CANO's P/E ratio is -0.01. In terms of profitability, LHCG's ROE is +0.04%, compared to CANO's ROE of -1.49%. Regarding short-term risk, LHCG is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
LHCG vs FPCG Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas FPCG's P/E ratio is 0.09. In terms of profitability, LHCG's ROE is +0.04%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, LHCG is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
LHCG vs AMS Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AMS trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AMS's P/E ratio is -5.90. In terms of profitability, LHCG's ROE is +0.04%, compared to AMS's ROE of -0.07%. Regarding short-term risk, LHCG is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
LHCG vs FTRP Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas FTRP's P/E ratio is -1.22. In terms of profitability, LHCG's ROE is +0.04%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, LHCG is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
LHCG vs BMGL Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, BMGL has a market cap of 7.3M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while BMGL trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas BMGL's P/E ratio is -0.88. In terms of profitability, LHCG's ROE is +0.04%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, LHCG is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
LHCG vs AIDX Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AIDX has a market cap of 6.9M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AIDX trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AIDX's P/E ratio is -1.06. In terms of profitability, LHCG's ROE is +0.04%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, LHCG is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
LHCG vs MODV Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas MODV's P/E ratio is -0.03. In terms of profitability, LHCG's ROE is +0.04%, compared to MODV's ROE of +1.36%. Regarding short-term risk, LHCG is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
LHCG vs GBNH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas GBNH's P/E ratio is -0.06. In terms of profitability, LHCG's ROE is +0.04%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, LHCG is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
LHCG vs RHE Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas RHE's P/E ratio is -1.79. In terms of profitability, LHCG's ROE is +0.04%, compared to RHE's ROE of -1.31%. Regarding short-term risk, LHCG is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
LHCG vs RHE-PA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, LHCG's ROE is +0.04%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, LHCG is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
LHCG vs TOIIW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, LHCG's ROE is +0.04%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, LHCG is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check TOIIW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
LHCG vs STLNW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, STLNW has a market cap of 4M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while STLNW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas STLNW's P/E ratio is -0.13. In terms of profitability, LHCG's ROE is +0.04%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, LHCG is more volatile compared to STLNW. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
LHCG vs IMACW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas IMACW's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, LHCG is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
LHCG vs EDVA Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, EDVA has a market cap of 1.6M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while EDVA trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas EDVA's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to EDVA's ROE of N/A. Regarding short-term risk, LHCG is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
LHCG vs EUDAW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while EUDAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, LHCG's ROE is +0.04%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, LHCG is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
LHCG vs CCM Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, CCM has a market cap of 605.8K. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while CCM trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas CCM's P/E ratio is -0.28. In terms of profitability, LHCG's ROE is +0.04%, compared to CCM's ROE of +0.06%. Regarding short-term risk, LHCG is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
LHCG vs NIVF Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while NIVF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas NIVF's P/E ratio is 0.56. In terms of profitability, LHCG's ROE is +0.04%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, LHCG is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
LHCG vs NIVFW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, NIVFW has a market cap of 43.2K. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, LHCG's ROE is +0.04%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, LHCG is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
LHCG vs MNDR Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, MNDR has a market cap of 36.9K. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while MNDR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas MNDR's P/E ratio is -0.04. In terms of profitability, LHCG's ROE is +0.04%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, LHCG is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
LHCG vs TALKW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas TALKW's P/E ratio is 0.00. In terms of profitability, LHCG's ROE is +0.04%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, LHCG is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check TALKW's competition here
Hanger, Inc. (NYSE: HNGR)
LHCG vs HNGR Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas HNGR's P/E ratio is 19.71. In terms of profitability, LHCG's ROE is +0.04%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, LHCG is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
LHCG vs SLHG Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas SLHG's P/E ratio is -1.48. In terms of profitability, LHCG's ROE is +0.04%, compared to SLHG's ROE of N/A. Regarding short-term risk, LHCG is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
LHCG vs AFAM Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas AFAM's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, LHCG is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
LHCG vs TLMD Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas TLMD's P/E ratio is -1.60. In terms of profitability, LHCG's ROE is +0.04%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, LHCG is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check TLMD's competition here
New Frontier Health Corporation (NYSE: NFH)
LHCG vs NFH Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, NFH has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas NFH's P/E ratio is -19.75. In terms of profitability, LHCG's ROE is +0.04%, compared to NFH's ROE of -0.06%. Regarding short-term risk, LHCG is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check NFH's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
LHCG vs TLMDW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas TLMDW's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, LHCG is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check TLMDW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
LHCG vs KND Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, KND has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas KND's P/E ratio is -1.14. In terms of profitability, LHCG's ROE is +0.04%, compared to KND's ROE of -0.53%. Regarding short-term risk, LHCG is less volatile compared to KND. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check KND's competition here
DocGo Inc. (NASDAQ: DCGOW)
LHCG vs DCGOW Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas DCGOW's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, LHCG is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check DCGOW's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
LHCG vs SLHGP Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, LHCG's ROE is +0.04%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, LHCG is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check SLHGP's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
LHCG vs DVCR Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas DVCR's P/E ratio is 28.34. In terms of profitability, LHCG's ROE is +0.04%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, LHCG is less volatile compared to DVCR. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check DVCR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
LHCG vs ATIP-WT Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, LHCG's ROE is +0.04%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, LHCG is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for LHCG.Check ATIP-WT's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
LHCG vs TVTY Comparison September 2026
LHC Group, Inc. (NASDAQ: LHCG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LHCG stands at 5.3B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, LHCG is priced at $169.81 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LHCG currently has a P/E ratio of 82.83, whereas TVTY's P/E ratio is 19.06. In terms of profitability, LHCG's ROE is +0.04%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, LHCG is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for LHCG.Check TVTY's competition here